Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

13.05p
   
  • Change Today:
      2.20p
  • 52 Week High: 13.45p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 11,110,098
  • Market Cap: £65.21m
  • RiskGrade: 328

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £194,244
Lisa Baderoon 583,963 £76,207
Tim Franklin 525,000 £68,512

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £5,865,446
Luca & Associates AG 22,000,000 £2,871,000
Invesco Ltd 17,872,341 £2,332,340
Aviva Investors Global 11,285,180 £1,472,716
Alora Pharmaceuticals LLC 10,909,091 £1,423,636
M&G Investments 7,600,000 £991,800
Prudential plc 7,600,000 £991,800
Capital Income Builder 4,870,367 £635,583
Dr R Zimmer 4,551,553 £593,978
Odey Asset Management 3,433,319 £448,048
Rhone Trustees (Switzerland) SA 3,386,000 £441,873
Pictet Overseas Trust Corporation Limited 3,287,500 £429,019

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 13.05p
Change Today 2.20p
% Change 20.28 %
52 Week High 13.45p
52 Week Low 1.09p
Volume 11,110,098
Shares Issued 499.72m
Market Cap £65.21m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 12-Sep-2025

Time Volume / Share Price
12:59 7,925 @ 12.67p
12:58 15,487 @ 12.88p
12:56 7,692 @ 12.55p
12:56 23,739 @ 12.67p
12:56 34,210 @ 12.67p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page